1-4 of 4
Christiane Pott
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

Clinical Trials & Observations
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A. Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3911–3920.
https://doi.org/10.1182/bloodadvances.2021006520
Published: 2022
Includes: Supplemental data
Journal Articles

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

James Peter Stewart, Jana Gazdova, Nikos Darzentas, Dörte Wren, Paula Proszek, Grazia Fazio, Simona Songia, Miguel Alcoceba, Maria Eugenia Sarasquete, Patrick Villarese, Michèle Y. van der Klift, Kim C. Heezen, Neil McCafferty, Karol Pal, Mark Catherwood, Chang Sik Kim, Shambhavi Srivastava, Leonie I. Kroeze, Elizabeth Hodges, Kostas Stamatopoulos, Wolfram Klapper, Elisa Genuardi, Simone Ferrero, Michiel van den Brand, Giovanni Cazzaniga, Frederic Davi, Lesley-Ann Sutton, Ramon Garcia-Sanz, Patricia J. T. A. Groenen, Elizabeth A. Macintyre, Monika Brüggemann, Christiane Pott, Anton W. Langerak, David Gonzalez, on behalf of the EuroClonality-NGS Working Group
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3188–3198.
https://doi.org/10.1182/bloodadvances.2020004056
Published: 2021
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data
Journal Articles

Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Clinical Trials & Observations
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, Sarah Haebe, Verena Passerini, Johannes C. Hellmuth, Erik Gaitzsch, William Keay, Natyra Tahiri, Anna Zoellner, Andreas Rosenwald, Wolfram Klapper, Harald Stein, Alfred Feller, German Ott, Annette M. Staiger, Heike Horn, Martin L. Hansmann, Christiane Pott, Michael Unterhalt, Christian Schmidt, Martin Dreyling, Ash A. Alizadeh, Wolfgang Hiddemann, Eva Hoster, Oliver Weigert
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4451–4462.
https://doi.org/10.1182/bloodadvances.2020002546
Published: 2020
Includes: Supplemental data